Artal Group S.A. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,770
-19.7%
1,000,0000.0%0.33%
+11.0%
Q2 2023$9,680
-11.7%
1,000,0000.0%0.30%
-53.9%
Q1 2023$10,960
+153.7%
1,000,0000.0%0.65%
+170.1%
Q4 2022$4,320
-99.9%
1,000,0000.0%0.24%
-24.9%
Q3 2022$7,520,000
-25.2%
1,000,0000.0%0.32%
-40.2%
Q2 2022$10,050,000
-18.8%
1,000,0000.0%0.54%
+3.7%
Q1 2022$12,380,000
-45.9%
1,000,0000.0%0.52%
-16.6%
Q4 2021$22,870,000
+3.3%
1,000,0000.0%0.62%
+25.5%
Q3 2021$22,130,000
+70.8%
1,000,0000.0%0.50%
+88.2%
Q2 2021$12,960,000
-0.2%
1,000,0000.0%0.26%
+14.8%
Q1 2021$12,985,000
-6.1%
1,000,0000.0%0.23%
-22.9%
Q4 2020$13,830,000
-6.1%
1,000,0000.0%0.30%
-17.0%
Q3 2020$14,730,000
+0.7%
1,000,000
+11.1%
0.36%
-12.5%
Q2 2020$14,625,000
+34.4%
900,000
+20.0%
0.41%
-11.1%
Q1 2020$10,883,000750,0000.46%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders